speb/financial-data huggingface dataset:
CBNK balance_sheet (quarterly, 2025-09-30) — Share Issued: 16589241.00
CBNK income_statement (quarterly, 2025-09-30) — Special Income Charges: -697000.00
CBNK cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 227000.00
CBNK balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 394770000.00
CBNK balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 353768000.00
CBNK income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -168674.00
CBNK income_statement (quarterly, 2025-09-30) — Tax Provision: 4802000.00
CBNK income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
CBNK balance_sheet (quarterly, 2025-09-30) — Total Assets: 3389442000.00
CBNK balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 428832000.00
CBNK balance_sheet (quarterly, 2025-09-30) — Total Debt: 34062000.00
CBNK balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 394770000.00
CBNK balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2994672000.00
CBNK income_statement (quarterly, 2025-09-30) — Total Unusual Items: -697000.00
CBNK income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -697000.00
CBNK income_statement (annual, 2025-12-31) — +Total Revenue: 241191000.00
CBNK income_statement (quarterly, 2025-12-31) — +Total Revenue: 61591000.00
CBNK balance_sheet (annual, 2025-12-31) — Accounts Payable: 8745000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8745000.00
CBNK balance_sheet (annual, 2025-12-31) — Accounts Receivable: 16695000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 16695000.00
CBNK balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -13507000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -13507000.00
CBNK balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 114604000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 114604000.00
CBNK cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1046000.00
CBNK cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 262000.00
CBNK cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1046000.00
CBNK cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 262000.00
CBNK cash_flow (annual, 2025-12-31) — Amortization Of Securities: -150000.00
CBNK cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -111000.00
CBNK balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 124300000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 124300000.00
CBNK income_statement (annual, 2025-12-31) — Basic Average Shares: 16582000.00
CBNK income_statement (quarterly, 2025-12-31) — Basic Average Shares: 16493000.00
CBNK income_statement (annual, 2025-12-31) — Basic EPS: 3.45
CBNK income_statement (quarterly, 2025-12-31) — Basic EPS: 0.91
CBNK cash_flow (annual, 2025-12-31) — Beginning Cash Position: 205332000.00
CBNK cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 188861000.00
CBNK balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 6380000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 6380000.00
CBNK cash_flow (annual, 2025-12-31) — Capital Expenditure: -2374000.00
CBNK cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -421000.00
CBNK balance_sheet (annual, 2025-12-31) — Capital Stock: 164000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Capital Stock: 164000.00
CBNK balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 255505000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 255505000.00
CBNK balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 263962000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 263962000.00
CBNK cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -7296000.00
CBNK cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1981000.00
CBNK balance_sheet (annual, 2025-12-31) — Cash Financial: 30894000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Cash Financial: 30894000.00
CBNK cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 331392000.00
CBNK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 189683000.00
CBNK cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -350880000.00
CBNK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -141432000.00
CBNK cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 69721000.00
CBNK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 18453000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Account Payable: -648000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 700000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -3024000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 1961000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -3437000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -3058000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 4627000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 7558000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Payable: -3672000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Payable: 2661000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3672000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2661000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Receivables: -31000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2316000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Tax Payable: -3024000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 1961000.00
CBNK cash_flow (annual, 2025-12-31) — Change In Working Capital: -2513000.00
CBNK cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 9477000.00
CBNK cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -31000.00
CBNK cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 2316000.00
CBNK cash_flow (annual, 2025-12-31) — Changes In Cash: 50233000.00
CBNK cash_flow (quarterly, 2025-12-31) — Changes In Cash: 66704000.00
CBNK balance_sheet (annual, 2025-12-31) — Common Stock: 164000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Common Stock: 164000.00
CBNK cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -7296000.00
CBNK cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -1981000.00
CBNK balance_sheet (annual, 2025-12-31) — Common Stock Equity: 401757000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 401757000.00
CBNK cash_flow (annual, 2025-12-31) — Common Stock Payments: -11731000.00
CBNK cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -8556000.00
CBNK balance_sheet (annual, 2025-12-31) — Construction In Progress: 115000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 115000.00
CBNK cash_flow (annual, 2025-12-31) — Deferred Income Tax: 1097000.00
CBNK cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -450000.00
CBNK cash_flow (annual, 2025-12-31) — Deferred Tax: 1097000.00
CBNK cash_flow (quarterly, 2025-12-31) — Deferred Tax: -450000.00
CBNK cash_flow (annual, 2025-12-31) — Depreciation: 2826000.00
CBNK cash_flow (quarterly, 2025-12-31) — Depreciation: 652000.00
CBNK cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3872000.00
CBNK cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 914000.00
CBNK cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3872000.00
CBNK cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 914000.00
CBNK income_statement (annual, 2025-12-31) — Diluted Average Shares: 16768000.00
CBNK income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 16493000.00
CBNK income_statement (annual, 2025-12-31) — Diluted EPS: 3.41
CBNK income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.91
CBNK income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 15037000.00
CBNK cash_flow (annual, 2025-12-31) — End Cash Position: 255565000.00
CBNK cash_flow (quarterly, 2025-12-31) — End Cash Position: 255565000.00
CBNK cash_flow (annual, 2025-12-31) — Financing Cash Flow: 331392000.00
CBNK cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 189683000.00
CBNK cash_flow (annual, 2025-12-31) — Free Cash Flow: 67347000.00
CBNK cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 18032000.00
CBNK income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 0.00
CBNK balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -5760000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -5760000.00
CBNK income_statement (annual, 2025-12-31) — General And Administrative Expense: 72169000.00
CBNK income_statement (quarterly, 2025-12-31) — General And Administrative Expense: -4372000.00
CBNK balance_sheet (annual, 2025-12-31) — Goodwill: 25969000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Goodwill: 25969000.00
CBNK balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 40740000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 40740000.00
CBNK balance_sheet (annual, 2025-12-31) — Gross PPE: 28579000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Gross PPE: 28579000.00
CBNK cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 18753000.00
CBNK cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 2813000.00
CBNK income_statement (annual, 2025-12-31) — Interest Expense: 64879000.00
CBNK income_statement (quarterly, 2025-12-31) — Interest Expense: 18355000.00
CBNK income_statement (annual, 2025-12-31) — Interest Income: 260871000.00
CBNK income_statement (quarterly, 2025-12-31) — Interest Income: 68634000.00
CBNK cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 65527000.00
CBNK cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 17655000.00
CBNK balance_sheet (annual, 2025-12-31) — Invested Capital: 453819000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Invested Capital: 453819000.00
CBNK cash_flow (annual, 2025-12-31) — Investing Cash Flow: -350880000.00
CBNK cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -141432000.00
CBNK balance_sheet (annual, 2025-12-31) — Investments And Advances: 229083000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 229083000.00
CBNK cash_flow (annual, 2025-12-31) — Issuance Of Debt: 28000000.00
CBNK balance_sheet (annual, 2025-12-31) — Land And Improvements: 700000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 700000.00
CBNK balance_sheet (annual, 2025-12-31) — Leases: 3068000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Leases: 3068000.00
CBNK balance_sheet (annual, 2025-12-31) — Long Term Debt: 52062000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 52062000.00
CBNK balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 52062000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 52062000.00
CBNK cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 28000000.00
CBNK cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -10000000.00
CBNK balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 11338000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 11338000.00
CBNK cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CBNK cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -11731000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -8556000.00
CBNK income_statement (annual, 2025-12-31) — Net Income: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Income: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 15037000.00
CBNK cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 57170000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 57170000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Net Interest Income: 195992000.00
CBNK income_statement (quarterly, 2025-12-31) — Net Interest Income: 50279000.00
CBNK cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1231000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 4032000.00
CBNK cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 18000000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 18000000.00
CBNK cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 18000000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 18000000.00
CBNK cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -3918000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1340000.00
CBNK balance_sheet (annual, 2025-12-31) — Net PPE: 15072000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Net PPE: 15072000.00
CBNK cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2374000.00
CBNK cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -421000.00
CBNK balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 361017000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 361017000.00
CBNK income_statement (annual, 2025-12-31) — Normalized Income: 59733770.80
CBNK income_statement (quarterly, 2025-12-31) — Normalized Income: 15037000.00
CBNK income_statement (annual, 2025-12-31) — Occupancy And Equipment: 11392000.00
CBNK income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 2638000.00
CBNK cash_flow (annual, 2025-12-31) — Operating Cash Flow: 69721000.00
CBNK cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 18453000.00
CBNK cash_flow (annual, 2025-12-31) — Operating Gains Losses: 2052000.00
CBNK cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -309000.00
CBNK income_statement (annual, 2025-12-31) — Operating Revenue: 241191000.00
CBNK income_statement (quarterly, 2025-12-31) — Operating Revenue: 61591000.00
CBNK balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 16373288.00
CBNK balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 16373288.00
CBNK balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -5760000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -5760000.00
CBNK balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 14771000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 14771000.00
CBNK cash_flow (annual, 2025-12-31) — Other Non Cash Items: -8647000.00
CBNK cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -10468000.00
CBNK income_statement (annual, 2025-12-31) — Other Non Interest Expense: 46951000.00
CBNK income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 33993000.00
CBNK balance_sheet (annual, 2025-12-31) — Other Properties: 6978000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Other Properties: 6978000.00
CBNK balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 104783000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 104783000.00
CBNK balance_sheet (annual, 2025-12-31) — Payables: 8745000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Payables: 8745000.00
CBNK balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 8745000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 8745000.00
CBNK cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 2114000.00
CBNK cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 403000.00
CBNK income_statement (annual, 2025-12-31) — Pretax Income: 74944000.00
CBNK income_statement (quarterly, 2025-12-31) — Pretax Income: 19681000.00
CBNK cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1158000.00
CBNK cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1073000.00
CBNK income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 10959000.00
CBNK income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 4294000.00
CBNK cash_flow (annual, 2025-12-31) — Purchase Of Investment: -54876000.00
CBNK cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -19716000.00
CBNK cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2374000.00
CBNK cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -421000.00
CBNK balance_sheet (annual, 2025-12-31) — Receivables: 16695000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Receivables: 16695000.00
CBNK income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3872000.00
CBNK income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 914000.00
CBNK cash_flow (annual, 2025-12-31) — Repayment Of Debt: -10000000.00
CBNK cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -11731000.00
CBNK cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -8556000.00
CBNK income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 3361000.00
CBNK income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CBNK balance_sheet (annual, 2025-12-31) — Retained Earnings: 292749000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 292749000.00
CBNK income_statement (annual, 2025-12-31) — Salaries And Wages: 72169000.00
CBNK income_statement (quarterly, 2025-12-31) — Salaries And Wages: 17914000.00
CBNK cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CBNK cash_flow (annual, 2025-12-31) — Sale Of Investment: 56107000.00
CBNK cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 23748000.00
CBNK income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 6262000.00
CBNK income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1398000.00
CBNK income_statement (annual, 2025-12-31) — Selling General And Administration: 78431000.00
CBNK income_statement (quarterly, 2025-12-31) — Selling General And Administration: -2974000.00
CBNK balance_sheet (annual, 2025-12-31) — Share Issued: 16373288.00
CBNK balance_sheet (quarterly, 2025-12-31) — Share Issued: 16373288.00
CBNK income_statement (annual, 2025-12-31) — Special Income Charges: -3361000.00
CBNK income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CBNK cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1608000.00
CBNK cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 378000.00
CBNK balance_sheet (annual, 2025-12-31) — Stockholders Equity: 401757000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 401757000.00
CBNK balance_sheet (annual, 2025-12-31) — Tangible Book Value: 361017000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 361017000.00
CBNK income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -797229.20
CBNK income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBNK income_statement (annual, 2025-12-31) — Tax Provision: 17774000.00
CBNK income_statement (quarterly, 2025-12-31) — Tax Provision: 4644000.00
CBNK income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CBNK income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
CBNK balance_sheet (annual, 2025-12-31) — Total Assets: 3606207000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Total Assets: 3606207000.00
CBNK balance_sheet (annual, 2025-12-31) — Total Capitalization: 453819000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 453819000.00
CBNK balance_sheet (annual, 2025-12-31) — Total Debt: 52062000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Total Debt: 52062000.00
CBNK balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 401757000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 401757000.00
CBNK balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3204450000.00
CBNK balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3204450000.00
CBNK income_statement (annual, 2025-12-31) — Total Unusual Items: -3361000.00
CBNK income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CBNK income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3361000.00
CBNK income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CBNK income_statement (quarterly, 2026-03-31) — +Total Revenue: 61388000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8944000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 16795000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 112268000.00
CBNK cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 260000.00
CBNK cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 260000.00
CBNK cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -92000.00
CBNK income_statement (quarterly, 2026-03-31) — Basic Average Shares: 16345000.00
CBNK income_statement (quarterly, 2026-03-31) — Basic EPS: 0.74
CBNK cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 255565000.00
CBNK cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -643000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Capital Stock: 163000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 399251000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 408002000.00
CBNK cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -1959000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Cash Financial: 20182000.00
CBNK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 194039000.00
CBNK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -72069000.00
CBNK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 21776000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 199000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 3461000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 306000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -10771000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Payable: 3660000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3660000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Receivables: -100000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 3461000.00
CBNK cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -6905000.00
CBNK cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -100000.00
CBNK cash_flow (quarterly, 2026-03-31) — Changes In Cash: 143746000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Common Stock: 163000.00
CBNK cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -1959000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 408859000.00
CBNK cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -3557000.00
CBNK cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -436000.00
CBNK cash_flow (quarterly, 2026-03-31) — Deferred Tax: -436000.00
CBNK cash_flow (quarterly, 2026-03-31) — Depreciation: 1157000.00
CBNK cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1417000.00
CBNK cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1417000.00
CBNK income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 16441000.00
CBNK income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.73
CBNK income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 12018000.00
CBNK cash_flow (quarterly, 2026-03-31) — End Cash Position: 399311000.00
CBNK cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 194039000.00
CBNK cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 21133000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -6380000.00
CBNK income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 20317000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Goodwill: 25969000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 40480000.00
CBNK cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 40000.00
CBNK income_statement (quarterly, 2026-03-31) — Interest Expense: 18572000.00
CBNK income_statement (quarterly, 2026-03-31) — Interest Income: 67970000.00
CBNK cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 18373000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Invested Capital: 460921000.00
CBNK cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -72069000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 229625000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 52062000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 52062000.00
CBNK cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -3557000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Income: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 12018000.00
CBNK cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Net Interest Income: 49398000.00
CBNK cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1164000.00
CBNK cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -294000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Net PPE: 17732000.00
CBNK cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -643000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 368379000.00
CBNK income_statement (quarterly, 2026-03-31) — Normalized Income: 12018000.00
CBNK income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 3562000.00
CBNK cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 21776000.00
CBNK cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 492000.00
CBNK income_statement (quarterly, 2026-03-31) — Operating Revenue: 61388000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 16286480.00
CBNK balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -6380000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 14511000.00
CBNK cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 11535000.00
CBNK income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 11988000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 229625000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Payables: 8944000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 8944000.00
CBNK cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 462000.00
CBNK income_statement (quarterly, 2026-03-31) — Pretax Income: 15871000.00
CBNK cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 708000.00
CBNK income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 4965000.00
CBNK cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -9490000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Receivables: 16795000.00
CBNK income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1417000.00
CBNK cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -3557000.00
CBNK income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
CBNK balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 302808000.00
CBNK income_statement (quarterly, 2026-03-31) — Salaries And Wages: 20317000.00
CBNK cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 8326000.00
CBNK income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1466000.00
CBNK income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21783000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Share Issued: 16286480.00
CBNK income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CBNK cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 512000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 408859000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 368379000.00
CBNK income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CBNK income_statement (quarterly, 2026-03-31) — Tax Provision: 3853000.00
CBNK income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
CBNK balance_sheet (quarterly, 2026-03-31) — Total Assets: 3808467000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 460921000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Total Debt: 52062000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 408859000.00
CBNK balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3399608000.00
CBNK income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
CBNK income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CBO.AX income_statement (annual, 2022-06-30) — +Operating Expense: 53265000.00
CBO.AX income_statement (annual, 2022-06-30) — +Total Revenue: 139617000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 17197000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 8784000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -101097000.00
CBO.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 402313548.00
CBO.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.00
CBO.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 1175000.00
CBO.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -36712000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 5459000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 179756000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 5944000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 5944000.00
CBO.AX cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -11606000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 5944000.00
CBO.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 14078000.00
CBO.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -36695000.00
CBO.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: 27386000.00
CBO.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 4769000.00
CBO.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -121701000.00
CBO.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 155509000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Common Stock: 179756000.00
CBO.AX cash_flow (annual, 2022-06-30) — Common Stock Dividend Paid: -11606000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 287029000.00
CBO.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 55545000.00
CBO.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 99659000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Assets: 132712000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 240000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Debt: 3925000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 4165000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 4393000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 1544000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Deferred Taxes Liabilities: 2849000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 38652000.00
CBO.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 17678000.00
CBO.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 17678000.00
CBO.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 17678000.00
CBO.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 402313548.00
CBO.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.00
CBO.AX income_statement (annual, 2022-06-30) — EBIT: 7199000.00
CBO.AX income_statement (annual, 2022-06-30) — EBITDA: 24877000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Employee Benefits: 59000.00
CBO.AX cash_flow (annual, 2022-06-30) — End Cash Position: 5944000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Financial Assets: 4525000.00
CBO.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 14078000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Finished Goods: 104459000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Fixed Assets Revaluation Reserve: 65667000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: -3948000.00
CBO.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -9326000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 65757000.00
CBO.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 17279000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 6678000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 500170000.00
CBO.AX income_statement (annual, 2022-06-30) — Gross Profit: 39958000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Hedging Assets Current: 41000.00
CBO.AX cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 866000.00
CBO.AX income_statement (annual, 2022-06-30) — Interest Expense: 4676000.00
CBO.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 4676000.00
CBO.AX income_statement (annual, 2022-06-30) — Interest Income: 388000.00
CBO.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 388000.00
CBO.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -5556000.00
CBO.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 5556000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Inventory: 116022000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 428279000.00
CBO.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -36695000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Investmentin Financial Assets: 10000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Investments And Advances: 10000.00
CBO.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 55545000.00
CBO.AX cash_flow (annual, 2022-06-30) — Issuance Of Debt: 20941000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Land And Improvements: 179105000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 5219000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Long Term Debt: 137325000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 142544000.00
CBO.AX cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 20941000.00
CBO.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -50594000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 112367000.00
CBO.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 55545000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Net Debt: 135306000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Income: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Interest Income: -4506000.00
CBO.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -29653000.00
CBO.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -29653000.00
CBO.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -4506000.00
CBO.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -208000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Net PPE: 399073000.00
CBO.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -36695000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 280351000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Non Current Accounts Receivable: 7611000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Non Current Deferred Liabilities: 74730000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Liabilities: 74730000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 59000.00
CBO.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: 24877000.00
CBO.AX income_statement (annual, 2022-06-30) — Normalized Income: -696000.00
CBO.AX income_statement (annual, 2022-06-30) — Operating Income: -13307000.00
CBO.AX income_statement (annual, 2022-06-30) — Operating Revenue: 139617000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 414500504.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 194000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Current Borrowings: 3925000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 1941000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 4038000.00
CBO.AX income_statement (annual, 2022-06-30) — Other Gand A: 14055000.00
CBO.AX income_statement (annual, 2022-06-30) — Other Income Expense: 2658000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 6678000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Inventories: 3265000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 7595000.00
CBO.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 2658000.00
CBO.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 487000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Payable: 9153000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Properties: 208698000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 850000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Payables: 26350000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 26350000.00
CBO.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -121701000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1803000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 1308000.00
CBO.AX income_statement (annual, 2022-06-30) — Pretax Income: 2523000.00
CBO.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -36712000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Raw Materials: 8298000.00
CBO.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 155509000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Receivables: 9203000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Receivables Adjustments Allowances: -431000.00
CBO.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 99659000.00
CBO.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 17678000.00
CBO.AX income_statement (annual, 2022-06-30) — Rent And Landing Fees: 3224000.00
CBO.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -50594000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: 41516000.00
CBO.AX cash_flow (annual, 2022-06-30) — Sale Of PPE: 17000.00
CBO.AX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 17821000.00
CBO.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 35100000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Share Issued: 414500504.00
CBO.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 287029000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 280351000.00
CBO.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
CBO.AX income_statement (annual, 2022-06-30) — Tax Provision: 3219000.00
CBO.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.30
CBO.AX cash_flow (annual, 2022-06-30) — Taxes Refund Paid Direct: -866000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Assets: 550609000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 424354000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Debt: 146709000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 287029000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 263580000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 417897000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 224928000.00
CBO.AX income_statement (annual, 2022-06-30) — Total Other Finance Cost: 218000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Trading Securities: 10000.00
CBO.AX balance_sheet (annual, 2022-06-30) — Working Capital: 94060000.00
CBO.AX income_statement (annual, 2023-06-30) — +Operating Expense: 60556000.00
CBO.AX income_statement (annual, 2023-06-30) — +Total Revenue: 168954000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 22159000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 13113000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -123594000.00
CBO.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 415215300.00
CBO.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.02
CBO.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 5944000.00
CBO.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -56024000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 5969000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 181698000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 13674000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 13674000.00
CBO.AX cash_flow (annual, 2023-06-30) — Cash Dividends Paid: -11738000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 13674000.00
CBO.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 24695000.00
CBO.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -55974000.00
CBO.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: 39009000.00
CBO.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 7730000.00
CBO.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -116422000.00
CBO.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 170546000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Common Stock: 181698000.00
CBO.AX cash_flow (annual, 2023-06-30) — Common Stock Dividend Paid: -11738000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 287789000.00
CBO.AX income_statement (annual, 2023-06-30) — Cost Of Revenue: 108713000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Assets: 140593000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 806000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Debt: 20016000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 20822000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Deferred Assets: 1606000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 2725000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 2725000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Deferred Taxes Assets: 1606000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 59871000.00
CBO.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 18085000.00
CBO.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 18085000.00
CBO.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 18085000.00
CBO.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 415215300.00
CBO.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.02
CBO.AX income_statement (annual, 2023-06-30) — EBIT: 22637000.00
CBO.AX income_statement (annual, 2023-06-30) — EBITDA: 40722000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Employee Benefits: 132000.00
CBO.AX cash_flow (annual, 2023-06-30) — End Cash Position: 13674000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Financial Assets: 3614000.00
CBO.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 24695000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Finished Goods: 94885000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Fixed Assets Revaluation Reserve: 66428000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: -492000.00
CBO.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -17015000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 70343000.00
CBO.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 20732000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 6678000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 575463000.00
CBO.AX income_statement (annual, 2023-06-30) — Gross Profit: 60241000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Hedging Assets Current: 1273000.00
CBO.AX cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 5176000.00
CBO.AX income_statement (annual, 2023-06-30) — Interest Expense: 8327000.00
CBO.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 8327000.00
CBO.AX income_statement (annual, 2023-06-30) — Interest Income: 392000.00
CBO.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 392000.00
CBO.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -10240000.00
CBO.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 10240000.00
CBO.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 301000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Inventories Adjustments Allowances: -1021000.00
CBO.AX balance_sheet (annual, 2023-06-30) — Inventory: 101759000.00